Top compounds associated with response to UBD


Feature Type Standardized
Nominal ANOVA
mRNA BRD-M00053801 CTRPv2 pan-cancer AAC -0.032 0.5
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.025 0.5
mRNA Gemcitabine CTRPv2 pan-cancer AAC 0.023 0.5
mRNA compound 1B CTRPv2 pan-cancer AAC -0.027 0.5
mRNA TG-101348 CTRPv2 pan-cancer AAC 0.023 0.5
mRNA avrainvillamide CTRPv2 pan-cancer AAC -0.027 0.5
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.024 0.5
mRNA PF-573228 CTRPv2 pan-cancer AAC -0.023 0.5
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.024 0.5
mRNA 1S,3R-RSL-3 CTRPv2 pan-cancer AAC -0.022 0.5
Download CSV